دورية أكاديمية
Successful treatment of critical coronavirus disease 2019 in a patient with lung cancer concomitant with pembrolizumab‐induced arthritis by methylprednisolone, baricitinib, and remdesivir
العنوان: | Successful treatment of critical coronavirus disease 2019 in a patient with lung cancer concomitant with pembrolizumab‐induced arthritis by methylprednisolone, baricitinib, and remdesivir |
---|---|
المؤلفون: | Naohiro Oda, Keiji Miyoshi, Daisuke Morichika, Yuka Beika, Takahiro Taki, Reo Mitani, Toshiaki Okada, Ichiro Takata |
المصدر: | Clinical Case Reports, Vol 9, Iss 7, Pp n/a-n/a (2021) |
بيانات النشر: | Wiley, 2021. |
سنة النشر: | 2021 |
المجموعة: | LCC:Medicine LCC:Medicine (General) |
مصطلحات موضوعية: | baricitinib, COVID‐19, immune checkpoint inhibitor, immune‐related adverse event, lung cancer, Medicine, Medicine (General), R5-920 |
الوصف: | Abstract COVID‐19 in cancer patients on immunosuppressive agents for the treatment of immune‐related adverse events of immune checkpoint inhibitors can rapidly deteriorate. The combination therapy with methylprednisolone, baricitinib, and remdesivir may be effective for critical COVID‐19, and further clinical trials are warranted. |
نوع الوثيقة: | article |
وصف الملف: | electronic resource |
اللغة: | English |
تدمد: | 2050-0904 |
Relation: | https://doaj.org/toc/2050-0904 |
DOI: | 10.1002/ccr3.4459 |
URL الوصول: | https://doaj.org/article/e1cf2529d28f48dfb3f0dab67d7fb366 |
رقم الأكسشن: | edsdoj.1cf2529d28f48dfb3f0dab67d7fb366 |
قاعدة البيانات: | Directory of Open Access Journals |
تدمد: | 20500904 |
---|---|
DOI: | 10.1002/ccr3.4459 |